Integrated DNA Technologies Unveils Innovative NGS Solution Industry Trends Gaining Momentum in the Global Next-Generation Oncology Devices And Solutions Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Next-Generation Oncology Devices And Solutions Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for next-generation oncology devices and solutions has seen a swift expansion in the last few years. It is projected to increase from $13.9 billion in 2024 to $16.41 billion in 2025 with a compound annual growth rate (CAGR) of 18.1%. The historic period's growth spur was facilitated by an increase in global cancer cases, development and expansion in oncology research and clinical trials, the surge of precision medicine, enhancements in hospital and diagnostic facilities, and an ascending awareness about early cancer detection.

Next-Generation Oncology Devices And Solutions Market Size Forecast: What's the Projected Valuation by 2029?
Expectations for the market size of next-generation oncology devices and solutions anticipate a swift expansion in the upcoming years, culminating in a value of $32.32 billion by 2029 with a compound annual growth rate (CAGR) of 18.5%. Contributors to this predicted growth throughout the forecast period include the aging international population, increasing investments in oncology startups, escalating healthcare-related expenditures, higher demand for non-invasive or minimally invasive diagnostic procedures, and expansion of healthcare infrastructures. The forecast period is projected to be characterized by key trends such as AI-driven diagnostic imaging, improvements in liquid biopsies, personalized medicine platforms, wearable devices for health monitoring, robotics, and less invasive surgical instruments.

View the full report here:
https://www.thebusinessresearchcompany.com/report/next-generation-oncology-devices-and-solutions-global-market-report

What Are the Drivers Transforming the Next-Generation Oncology Devices And Solutions Market?
The projected growth of the next-generation oncology devices and solutions market is primarily attributed to the rising prevalence of cancer. Cancer, characterized by the unregulated proliferation and spread of anomalous cells, interferes with normal bodily functions. Geriatric populations are more susceptible to developing cancer, making it a growing concern. The sophisticated oncology devices and solutions of the next generation facilitate the management of mounting cancer cases through enabling early detection, precise diagnosis, and customized treatment. The American Cancer Society, a renowned non-profit organization in the US, projected in January 2024 that there would be over 611,000 cancer-related fatalities in the country, translating to more than 1,600 daily deaths due to cancer. Consequently, the surge in cancer incidence would significantly foster the growth of the next-generation oncology devices and solutions market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24336&type=smp

What Are the Key Trends Driving Next-Generation Oncology Devices And Solutions Market Growth?
Prominent players in the next-generation oncology devices and solutions market are honing in on technological improvements, like next-generation sequencing (NGS) target enrichment solutions, to boost the identification of uncommon genetic variations, amplify sequencing precision, and expedite cancer diagnosis and treatment procedures. NGS target enrichment solutions are methods that selectively catch and enrich particular DNA or RNA areas for sequencing, facilitating more precise, efficient genetic variant analysis linked with illnesses like cancer. For example, in April 2025, US-based biotech firm Integrated DNA Technologies (IDT) launched the xGen Hybridization and Wash v3 Kit. This innovative solution is made to expedite cancer research by simplifying NGS workflows. It substantially cuts down the hybridization time to one hour, allowing scientists to finish sample preparation and transition to sequencing within a single workday. By abolishing the need for heated buffers and reducing hands-on time by 20%, this solution is exceptionally automation-friendly and ideal for high-throughput applications.

Which Segments in the Next-Generation Oncology Devices And Solutions Market Offer the Most Profit Potential?
The next-generation oncology devices and solutions market covered in this report is segmented -

1) By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies
3) By Application: Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications
4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses

Subsegments:
1) By Breast Cancer: Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
2) By Cervical Cancer: Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer
4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24336&type=smp

Which Firms Dominate the Next-Generation Oncology Devices And Solutions Market by Market Share and Revenue in 2025?
Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd.

Which Regions Offer the Highest Growth Potential in the Next-Generation Oncology Devices And Solutions Market?
North America was the largest region in the next-generation oncology devices and solutions market in 2024. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24336

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.